Edwards Lifesciences (EW) debt: $598M
Edwards Lifesciences had $598M of long-term debt on Dec 31, 2025, including the part due within a year, up 0.1% from $598M a year earlier.
From Edwards Lifesciences's filings with the SEC · Read the filing · EW stock page
Edwards Lifesciences debt by year
#1,054 of 2,129 US companies by debt · See the full ranking
| Year ended | Debt | Change |
|---|---|---|
| Dec 31, 2025 | $598M | +0% |
| Dec 31, 2024 | $598M | +0% |
| Dec 31, 2023 | $597M | +0% |
| Dec 31, 2022 | $596M | +0% |
| Dec 31, 2021 | $596M | – |
Debt of similar companies
Companies in the same industry as Edwards Lifesciences, by SEC industry code, with the closest debt. Each name opens the same page for that company.
| Company | Debt, latest year | Year ended |
|---|---|---|
| Zimmer Biomet Holdings | $7.5B | Dec 31, 2025 |
| STERIS | $1.9B | Dec 31, 2025 |
| Enovis | $1.3B | Dec 31, 2025 |
| Edwards Lifesciences | $598M | Dec 31, 2025 |
| MSA Safety | $581M | Dec 31, 2025 |
| Cadre Holdings | $307M | Dec 31, 2025 |
| Establishment Labs | $248M | Dec 31, 2025 |
Questions and answers
What is Edwards Lifesciences's debt?
Edwards Lifesciences had $598M of long-term debt on Dec 31, 2025, including the part due within a year, up 0.1% from $598M a year earlier.
Numbers as reported in Edwards Lifesciences's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology